4233 Technology Dr, Durham, NC 27704
This immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. The Keith Corporation built this 122,513 Sq. Ft. facility in Durham’s Research Triangle Park (RTP) with a large structural glass feature to embrace the high-tech feel of the company and the RTP.